Global Reach Medicines Discovery Catapult operates as a global centre of excellence with international collaborations across 15 countries and 4 continents, presenting opportunities to partner with multinational biotech and pharma developers seeking translational capabilities and cross-border program de-risking.

Full-Stack Accelerator The company offers end-to-end capabilities in radiopharmaceuticals, biomarkers, in vitro biology, and regulatory-aligned R&D consultancy, enabling potential customers to consolidate multiple translational needs under one partner to accelerate from concept to clinic.

Investor-Grade Data With a focus on de-risking programs and providing investor-grade data, MDC can support business development efforts for biotech firms seeking credible data packages to secure funding, partnerships, or advancing to Phase 0/clinical momentum.

Industrial Expertise A multi-disciplinary team of 140+ industry experts and world-class imaging facilities positions MDC as a trusted collaborator for pharma/biotech teams requiring rapid translational decisions, target engagement validation, and efficient project management.

Adjacent Partnerships Recent and ongoing collaborations across offshore energy and tech sectors indicate a proclivity for cross-industry partnerships and co-development opportunities that could be extended to life sciences clients exploring radiolabelling, imaging, and biomarker strategies.